ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0

CUSIP: 014339AA3

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Debt / NOTE 2.500% 2/0
Market price (% of par)
91.97%
Total 13F principal
$268,716,000
Principal change
+$268,716,000
Total reported market value
$248,126,000
Number of holders
41
Value change
+$248,126,000
Number of buys
41

Quarterly Holders Quick Answers

What is CUSIP 014339AA3?
CUSIP 014339AA3 identifies 014339AA3 - ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 as of Q1 2018

As of 31 Mar 2018, ALDER BIOPHARMACEUTICALS INC - NOTE 2.500% 2/0 was held by 41 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $268,716,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Redmile Group, LLC, Linden Advisors LP, Partner Fund Management, L.P., AMERIPRISE FINANCIAL INC, Allianz Asset Management GmbH, Myriad Asset Management Ltd., CQS Cayman LP, and CALAMOS ADVISORS LLC. This page lists 41 institutional bondholders reporting positions for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.